Inventor · disambiguated record
Joyce Harp
Also filed as: HARP JOYCE · HARP JOYCE B
11 granted patents·6 pending applications·104 citations·filing 2011–2025
90Inventor score
Top patents by PatentIndex Score
17 records- 0196US9358287B2Method of treating stress hyperglycemia with human antibodies to the glucagon receptorREGENERON PHARMA·Filed 2014·Granted Jun 7, 2016·21 cites·10 claims
- 0295US9587029B2Human antibodies to the glucagon receptor and methods of use thereofREGENERON PHARMA·Filed 2015·Granted Mar 7, 2017·15 cites·19 claims
- 0394US9127068B2Nucleic acids encoding human glucagon receptor antibodiesREGENERON PHARMA·Filed 2013·Granted Sep 8, 2015·20 cites·10 claims
- 0494US8771696B2Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptorREGENERON PHARMA·Filed 2013·Granted Jul 8, 2014·12 cites·22 claims
- 0594US8545847B2Human antibodies to the human glucagon receptor and methods of use thereofOKAMOTO HARUKA·Filed 2011·Granted Oct 1, 2013·32 cites·17 claims
- 0688US10233250B2Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levelsREGENERON PHARMA·Filed 2017·Granted Mar 19, 2019·4 cites·21 claims
- 0785US12269889B2Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levelsREGENERON PHARMA·Filed 2022·Granted Apr 8, 2025·0 cites·20 claims
- 0880US2025304704A1Human antibodies to the glucagon receptorREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0978US2023416384A1Methods of treating severe insulin resistance by interfering with glucagon receptor signalingREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1073US11708416B2Methods of treating severe insulin resistance by interfering with glucagon receptor signalingREGENERON PHARMA·Filed 2021·Granted Jul 25, 2023·0 cites·11 claims
- 1173US11498970B2Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levelsREGENERON PHARMA·Filed 2020·Granted Nov 15, 2022·0 cites·11 claims
- 1273US10640566B2Nucleic acid molecules encoding antibodies to the human glucagon receptorREGENERON PHARMA·Filed 2019·Granted May 5, 2020·0 cites·10 claims
- 1363US10995146B2Methods of treating severe insulin resistance by interfering with glucagon receptor signalingREGENERON PHARMA·Filed 2017·Granted May 4, 2021·0 cites·11 claims
- 1459US2016257757A1Method of treating stress hyperglycemia with human antibodies to the glucagon receptorREGENERON PHARMA·Filed 2016·Application pending·0 cites
- 1553US2018296672A1Methods for Treating Patients with Hypercholesterolemia that is not Adequately Controlled by Moderate-Dose Statin TherapyREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 1649US2015231236A1Methods for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapyREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 1744US2020405728A1Methods of preventing and treating hypoglycemia in type 1 and type 2 diabetes patientsFEROX THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joyce Harp files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →